 | • レポートコード：GIR-23F3828 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Human Immune Globulin Intravenous Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の人免疫グロブリン静注の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 人免疫グロブリン静注市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・液状IVIg、粉末状IVIg アプリケーション別セグメントは次のように区分されます。 ・免疫不全、自己免疫疾患、急性感染症 世界の人免疫グロブリン静注市場の主要なマーケットプレーヤーは以下のとおりです。 ・Takeda、Grifols、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Sichuan Yuanda Shuyang 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 人免疫グロブリン静注の概要 - タイプ別分析（2017年vs2021年vs2028年）：液状IVIg、粉末状IVIg - アプリケーション別分析（2017年vs2021年vs2028年）：免疫不全、自己免疫疾患、急性感染症 - 世界の人免疫グロブリン静注市場規模・予測 - 世界の人免疫グロブリン静注生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Takeda、Grifols、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Sichuan Yuanda Shuyang ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：液状IVIg、粉末状IVIg ・アプリケーション別分析2017年-2028年：免疫不全、自己免疫疾患、急性感染症 ・人免疫グロブリン静注の北米市場分析 - 人免疫グロブリン静注の北米市場：タイプ別市場規模2017年-2028年 - 人免疫グロブリン静注の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・人免疫グロブリン静注のヨーロッパ市場分析 - ：人免疫グロブリン静注のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：人免疫グロブリン静注のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・人免疫グロブリン静注のアジア太平洋市場分析 - 人免疫グロブリン静注のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 人免疫グロブリン静注のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・人免疫グロブリン静注の南米市場分析 - 人免疫グロブリン静注の南米市場：タイプ別市場規模2017年-2028年 - 人免疫グロブリン静注の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・人免疫グロブリン静注の中東・アフリカ市場分析 - 人免疫グロブリン静注の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 人免疫グロブリン静注の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Human Immune Globulin Intravenous market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Immune Globulin Intravenous market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Immunodeficiency accounting for % of the Human Immune Globulin Intravenous global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While IVIg Liquid segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Immune Globulin Intravenous include Takeda, Grifols, CSL, Octapharma, and Biotest, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Immune Globulin Intravenous market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
IVIg Liquid
IVIg Powder
Market segment by Application can be divided into
Immunodeficiency
Autoimmune Disease
Acute Infection
The key market players for global Human Immune Globulin Intravenous market are listed below:
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Immune Globulin Intravenous product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Immune Globulin Intravenous, with price, sales, revenue and global market share of Human Immune Globulin Intravenous from 2019 to 2022.
Chapter 3, the Human Immune Globulin Intravenous competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Immune Globulin Intravenous breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Immune Globulin Intravenous market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Immune Globulin Intravenous.
Chapter 13, 14, and 15, to describe Human Immune Globulin Intravenous sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Human Immune Globulin Intravenous Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Immune Globulin Intravenous Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Immune Globulin Intravenous Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Human Immune Globulin Intravenous Market Size & Forecast
1.4.1 Global Human Immune Globulin Intravenous Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Immune Globulin Intravenous Sales in Volume (2017-2028)
1.4.3 Global Human Immune Globulin Intravenous Price (2017-2028)
1.5 Global Human Immune Globulin Intravenous Production Capacity Analysis
1.5.1 Global Human Immune Globulin Intravenous Total Production Capacity (2017-2028)
1.5.2 Global Human Immune Globulin Intravenous Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Immune Globulin Intravenous Market Drivers
1.6.2 Human Immune Globulin Intravenous Market Restraints
1.6.3 Human Immune Globulin Intravenous Trends Analysis
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Human Immune Globulin Intravenous Product and Services
2.1.4 Takeda Human Immune Globulin Intravenous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Human Immune Globulin Intravenous Product and Services
2.2.4 Grifols Human Immune Globulin Intravenous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Human Immune Globulin Intravenous Product and Services
2.3.4 CSL Human Immune Globulin Intravenous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Human Immune Globulin Intravenous Product and Services
2.4.4 Octapharma Human Immune Globulin Intravenous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Biotest
2.5.1 Biotest Details
2.5.2 Biotest Major Business
2.5.3 Biotest Human Immune Globulin Intravenous Product and Services
2.5.4 Biotest Human Immune Globulin Intravenous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Kedrion
2.6.1 Kedrion Details
2.6.2 Kedrion Major Business
2.6.3 Kedrion Human Immune Globulin Intravenous Product and Services
2.6.4 Kedrion Human Immune Globulin Intravenous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hualan Bio
2.7.1 Hualan Bio Details
2.7.2 Hualan Bio Major Business
2.7.3 Hualan Bio Human Immune Globulin Intravenous Product and Services
2.7.4 Hualan Bio Human Immune Globulin Intravenous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CNBG
2.8.1 CNBG Details
2.8.2 CNBG Major Business
2.8.3 CNBG Human Immune Globulin Intravenous Product and Services
2.8.4 CNBG Human Immune Globulin Intravenous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Shanghai RAAS
2.9.1 Shanghai RAAS Details
2.9.2 Shanghai RAAS Major Business
2.9.3 Shanghai RAAS Human Immune Globulin Intravenous Product and Services
2.9.4 Shanghai RAAS Human Immune Globulin Intravenous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Human Immune Globulin Intravenous Product and Services
2.10.4 CBPO Human Immune Globulin Intravenous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 LFB Group
2.11.1 LFB Group Details
2.11.2 LFB Group Major Business
2.11.3 LFB Group Human Immune Globulin Intravenous Product and Services
2.11.4 LFB Group Human Immune Globulin Intravenous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 BPL
2.12.1 BPL Details
2.12.2 BPL Major Business
2.12.3 BPL Human Immune Globulin Intravenous Product and Services
2.12.4 BPL Human Immune Globulin Intravenous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Sichuan Yuanda Shuyang
2.13.1 Sichuan Yuanda Shuyang Details
2.13.2 Sichuan Yuanda Shuyang Major Business
2.13.3 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product and Services
2.13.4 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Immune Globulin Intravenous Breakdown Data by Manufacturer
3.1 Global Human Immune Globulin Intravenous Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Immune Globulin Intravenous Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Immune Globulin Intravenous
3.4 Market Concentration Rate
3.4.1 Top 3 Human Immune Globulin Intravenous Manufacturer Market Share in 2021
3.4.2 Top 6 Human Immune Globulin Intravenous Manufacturer Market Share in 2021
3.5 Global Human Immune Globulin Intravenous Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Immune Globulin Intravenous Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Immune Globulin Intravenous Market Size by Region
4.1.1 Global Human Immune Globulin Intravenous Sales in Volume by Region (2017-2028)
4.1.2 Global Human Immune Globulin Intravenous Revenue by Region (2017-2028)
4.2 North America Human Immune Globulin Intravenous Revenue (2017-2028)
4.3 Europe Human Immune Globulin Intravenous Revenue (2017-2028)
4.4 Asia-Pacific Human Immune Globulin Intravenous Revenue (2017-2028)
4.5 South America Human Immune Globulin Intravenous Revenue (2017-2028)
4.6 Middle East and Africa Human Immune Globulin Intravenous Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Immune Globulin Intravenous Sales in Volume by Type (2017-2028)
5.2 Global Human Immune Globulin Intravenous Revenue by Type (2017-2028)
5.3 Global Human Immune Globulin Intravenous Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Immune Globulin Intravenous Sales in Volume by Application (2017-2028)
6.2 Global Human Immune Globulin Intravenous Revenue by Application (2017-2028)
6.3 Global Human Immune Globulin Intravenous Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Immune Globulin Intravenous Sales by Type (2017-2028)
7.2 North America Human Immune Globulin Intravenous Sales by Application (2017-2028)
7.3 North America Human Immune Globulin Intravenous Market Size by Country
7.3.1 North America Human Immune Globulin Intravenous Sales in Volume by Country (2017-2028)
7.3.2 North America Human Immune Globulin Intravenous Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Immune Globulin Intravenous Sales by Type (2017-2028)
8.2 Europe Human Immune Globulin Intravenous Sales by Application (2017-2028)
8.3 Europe Human Immune Globulin Intravenous Market Size by Country
8.3.1 Europe Human Immune Globulin Intravenous Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Immune Globulin Intravenous Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Immune Globulin Intravenous Sales by Type (2017-2028)
9.2 Asia-Pacific Human Immune Globulin Intravenous Sales by Application (2017-2028)
9.3 Asia-Pacific Human Immune Globulin Intravenous Market Size by Region
9.3.1 Asia-Pacific Human Immune Globulin Intravenous Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Immune Globulin Intravenous Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Immune Globulin Intravenous Sales by Type (2017-2028)
10.2 South America Human Immune Globulin Intravenous Sales by Application (2017-2028)
10.3 South America Human Immune Globulin Intravenous Market Size by Country
10.3.1 South America Human Immune Globulin Intravenous Sales in Volume by Country (2017-2028)
10.3.2 South America Human Immune Globulin Intravenous Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Immune Globulin Intravenous Sales by Type (2017-2028)
11.2 Middle East & Africa Human Immune Globulin Intravenous Sales by Application (2017-2028)
11.3 Middle East & Africa Human Immune Globulin Intravenous Market Size by Country
11.3.1 Middle East & Africa Human Immune Globulin Intravenous Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Immune Globulin Intravenous Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Immune Globulin Intravenous and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Immune Globulin Intravenous
12.3 Human Immune Globulin Intravenous Production Process
12.4 Human Immune Globulin Intravenous Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Immune Globulin Intravenous Typical Distributors
13.3 Human Immune Globulin Intravenous Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Human Immune Globulin Intravenous Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Immune Globulin Intravenous Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Human Immune Globulin Intravenous Product and Services
Table 6. Takeda Human Immune Globulin Intravenous Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Grifols Basic Information, Manufacturing Base and Competitors
Table 8. Grifols Major Business
Table 9. Grifols Human Immune Globulin Intravenous Product and Services
Table 10. Grifols Human Immune Globulin Intravenous Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. CSL Basic Information, Manufacturing Base and Competitors
Table 12. CSL Major Business
Table 13. CSL Human Immune Globulin Intravenous Product and Services
Table 14. CSL Human Immune Globulin Intravenous Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Octapharma Basic Information, Manufacturing Base and Competitors
Table 16. Octapharma Major Business
Table 17. Octapharma Human Immune Globulin Intravenous Product and Services
Table 18. Octapharma Human Immune Globulin Intravenous Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Biotest Basic Information, Manufacturing Base and Competitors
Table 20. Biotest Major Business
Table 21. Biotest Human Immune Globulin Intravenous Product and Services
Table 22. Biotest Human Immune Globulin Intravenous Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Kedrion Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Major Business
Table 25. Kedrion Human Immune Globulin Intravenous Product and Services
Table 26. Kedrion Human Immune Globulin Intravenous Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 28. Hualan Bio Major Business
Table 29. Hualan Bio Human Immune Globulin Intravenous Product and Services
Table 30. Hualan Bio Human Immune Globulin Intravenous Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. CNBG Basic Information, Manufacturing Base and Competitors
Table 32. CNBG Major Business
Table 33. CNBG Human Immune Globulin Intravenous Product and Services
Table 34. CNBG Human Immune Globulin Intravenous Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 36. Shanghai RAAS Major Business
Table 37. Shanghai RAAS Human Immune Globulin Intravenous Product and Services
Table 38. Shanghai RAAS Human Immune Globulin Intravenous Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. CBPO Basic Information, Manufacturing Base and Competitors
Table 40. CBPO Major Business
Table 41. CBPO Human Immune Globulin Intravenous Product and Services
Table 42. CBPO Human Immune Globulin Intravenous Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. LFB Group Basic Information, Manufacturing Base and Competitors
Table 44. LFB Group Major Business
Table 45. LFB Group Human Immune Globulin Intravenous Product and Services
Table 46. LFB Group Human Immune Globulin Intravenous Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. BPL Basic Information, Manufacturing Base and Competitors
Table 48. BPL Major Business
Table 49. BPL Human Immune Globulin Intravenous Product and Services
Table 50. BPL Human Immune Globulin Intravenous Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 52. Sichuan Yuanda Shuyang Major Business
Table 53. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product and Services
Table 54. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Human Immune Globulin Intravenous Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 56. Global Human Immune Globulin Intravenous Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Human Immune Globulin Intravenous, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Human Immune Globulin Intravenous Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Human Immune Globulin Intravenous Production Site of Key Manufacturer
Table 60. Human Immune Globulin Intravenous New Entrant and Capacity Expansion Plans
Table 61. Human Immune Globulin Intravenous Mergers & Acquisitions in the Past Five Years
Table 62. Global Human Immune Globulin Intravenous Sales by Region (2017-2022) & (K Units)
Table 63. Global Human Immune Globulin Intravenous Sales by Region (2023-2028) & (K Units)
Table 64. Global Human Immune Globulin Intravenous Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Human Immune Globulin Intravenous Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)
Table 67. Global Human Immune Globulin Intravenous Sales by Type (2023-2028) & (K Units)
Table 68. Global Human Immune Globulin Intravenous Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Human Immune Globulin Intravenous Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Human Immune Globulin Intravenous Price by Type (2017-2022) & (USD/Unit)
Table 71. Global Human Immune Globulin Intravenous Price by Type (2023-2028) & (USD/Unit)
Table 72. Global Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)
Table 73. Global Human Immune Globulin Intravenous Sales by Application (2023-2028) & (K Units)
Table 74. Global Human Immune Globulin Intravenous Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Human Immune Globulin Intravenous Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Human Immune Globulin Intravenous Price by Application (2017-2022) & (USD/Unit)
Table 77. Global Human Immune Globulin Intravenous Price by Application (2023-2028) & (USD/Unit)
Table 78. North America Human Immune Globulin Intravenous Sales by Country (2017-2022) & (K Units)
Table 79. North America Human Immune Globulin Intravenous Sales by Country (2023-2028) & (K Units)
Table 80. North America Human Immune Globulin Intravenous Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Human Immune Globulin Intravenous Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)
Table 83. North America Human Immune Globulin Intravenous Sales by Type (2023-2028) & (K Units)
Table 84. North America Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)
Table 85. North America Human Immune Globulin Intravenous Sales by Application (2023-2028) & (K Units)
Table 86. Europe Human Immune Globulin Intravenous Sales by Country (2017-2022) & (K Units)
Table 87. Europe Human Immune Globulin Intravenous Sales by Country (2023-2028) & (K Units)
Table 88. Europe Human Immune Globulin Intravenous Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Human Immune Globulin Intravenous Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)
Table 91. Europe Human Immune Globulin Intravenous Sales by Type (2023-2028) & (K Units)
Table 92. Europe Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)
Table 93. Europe Human Immune Globulin Intravenous Sales by Application (2023-2028) & (K Units)
Table 94. Asia-Pacific Human Immune Globulin Intravenous Sales by Region (2017-2022) & (K Units)
Table 95. Asia-Pacific Human Immune Globulin Intravenous Sales by Region (2023-2028) & (K Units)
Table 96. Asia-Pacific Human Immune Globulin Intravenous Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Human Immune Globulin Intravenous Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)
Table 99. Asia-Pacific Human Immune Globulin Intravenous Sales by Type (2023-2028) & (K Units)
Table 100. Asia-Pacific Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)
Table 101. Asia-Pacific Human Immune Globulin Intravenous Sales by Application (2023-2028) & (K Units)
Table 102. South America Human Immune Globulin Intravenous Sales by Country (2017-2022) & (K Units)
Table 103. South America Human Immune Globulin Intravenous Sales by Country (2023-2028) & (K Units)
Table 104. South America Human Immune Globulin Intravenous Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Human Immune Globulin Intravenous Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)
Table 107. South America Human Immune Globulin Intravenous Sales by Type (2023-2028) & (K Units)
Table 108. South America Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)
Table 109. South America Human Immune Globulin Intravenous Sales by Application (2023-2028) & (K Units)
Table 110. Middle East & Africa Human Immune Globulin Intravenous Sales by Region (2017-2022) & (K Units)
Table 111. Middle East & Africa Human Immune Globulin Intravenous Sales by Region (2023-2028) & (K Units)
Table 112. Middle East & Africa Human Immune Globulin Intravenous Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Human Immune Globulin Intravenous Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)
Table 115. Middle East & Africa Human Immune Globulin Intravenous Sales by Type (2023-2028) & (K Units)
Table 116. Middle East & Africa Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)
Table 117. Middle East & Africa Human Immune Globulin Intravenous Sales by Application (2023-2028) & (K Units)
Table 118. Human Immune Globulin Intravenous Raw Material
Table 119. Key Manufacturers of Human Immune Globulin Intravenous Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Human Immune Globulin Intravenous Typical Distributors
Table 123. Human Immune Globulin Intravenous Typical Customers
List of Figures
Figure 1. Human Immune Globulin Intravenous Picture
Figure 2. Global Human Immune Globulin Intravenous Revenue Market Share by Type in 2021
Figure 3. IVIg Liquid
Figure 4. IVIg Powder
Figure 5. Global Human Immune Globulin Intravenous Revenue Market Share by Application in 2021
Figure 6. Immunodeficiency
Figure 7. Autoimmune Disease
Figure 8. Acute Infection
Figure 9. Global Human Immune Globulin Intravenous Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Human Immune Globulin Intravenous Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Human Immune Globulin Intravenous Sales (2017-2028) & (K Units)
Figure 12. Global Human Immune Globulin Intravenous Price (2017-2028) & (USD/Unit)
Figure 13. Global Human Immune Globulin Intravenous Production Capacity (2017-2028) & (K Units)
Figure 14. Global Human Immune Globulin Intravenous Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Human Immune Globulin Intravenous Market Drivers
Figure 16. Human Immune Globulin Intravenous Market Restraints
Figure 17. Human Immune Globulin Intravenous Market Trends
Figure 18. Global Human Immune Globulin Intravenous Sales Market Share by Manufacturer in 2021
Figure 19. Global Human Immune Globulin Intravenous Revenue Market Share by Manufacturer in 2021
Figure 20. Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Human Immune Globulin Intravenous Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Human Immune Globulin Intravenous Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Human Immune Globulin Intravenous Sales Market Share by Region (2017-2028)
Figure 24. Global Human Immune Globulin Intravenous Revenue Market Share by Region (2017-2028)
Figure 25. North America Human Immune Globulin Intravenous Revenue (2017-2028) & (USD Million)
Figure 26. Europe Human Immune Globulin Intravenous Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Human Immune Globulin Intravenous Revenue (2017-2028) & (USD Million)
Figure 28. South America Human Immune Globulin Intravenous Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Human Immune Globulin Intravenous Revenue (2017-2028) & (USD Million)
Figure 30. Global Human Immune Globulin Intravenous Sales Market Share by Type (2017-2028)
Figure 31. Global Human Immune Globulin Intravenous Revenue Market Share by Type (2017-2028)
Figure 32. Global Human Immune Globulin Intravenous Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Human Immune Globulin Intravenous Sales Market Share by Application (2017-2028)
Figure 34. Global Human Immune Globulin Intravenous Revenue Market Share by Application (2017-2028)
Figure 35. Global Human Immune Globulin Intravenous Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Human Immune Globulin Intravenous Sales Market Share by Type (2017-2028)
Figure 37. North America Human Immune Globulin Intravenous Sales Market Share by Application (2017-2028)
Figure 38. North America Human Immune Globulin Intravenous Sales Market Share by Country (2017-2028)
Figure 39. North America Human Immune Globulin Intravenous Revenue Market Share by Country (2017-2028)
Figure 40. United States Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Human Immune Globulin Intravenous Sales Market Share by Type (2017-2028)
Figure 44. Europe Human Immune Globulin Intravenous Sales Market Share by Application (2017-2028)
Figure 45. Europe Human Immune Globulin Intravenous Sales Market Share by Country (2017-2028)
Figure 46. Europe Human Immune Globulin Intravenous Revenue Market Share by Country (2017-2028)
Figure 47. Germany Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Human Immune Globulin Intravenous Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Human Immune Globulin Intravenous Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Human Immune Globulin Intravenous Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Human Immune Globulin Intravenous Revenue Market Share by Region (2017-2028)
Figure 56. China Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Human Immune Globulin Intravenous Sales Market Share by Type (2017-2028)
Figure 63. South America Human Immune Globulin Intravenous Sales Market Share by Application (2017-2028)
Figure 64. South America Human Immune Globulin Intravenous Sales Market Share by Country (2017-2028)
Figure 65. South America Human Immune Globulin Intravenous Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Human Immune Globulin Intravenous Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Human Immune Globulin Intravenous Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Human Immune Globulin Intravenous Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Human Immune Globulin Intravenous Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Human Immune Globulin Intravenous Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Human Immune Globulin Intravenous in 2021
Figure 77. Manufacturing Process Analysis of Human Immune Globulin Intravenous
Figure 78. Human Immune Globulin Intravenous Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source